- Presentations
- 3
- Markets
- 1
Advair HFA is a brand of Fluticasone propionate and Salmeterol marketed by GlaxoSmithKline, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Fluticasone propionate and Salmeterol
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- 115 mcg/21 mcg inhaler, 230 mcg/21 mcg inhaler, 45 mcg/21 mcg inhaler
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Advair HFA 115 mcg/21 mcg inhalerInhalation | GlaxoSmithKline | US FDA | Available on request |
| Advair HFA 230 mcg/21 mcg inhalerInhalation | GlaxoSmithKline | US FDA | Available on request |
| Advair HFA 45 mcg/21 mcg inhalerInhalation | GlaxoSmithKline | US FDA | Available on request |
Equivalent brands
Other brands of Fluticasone propionate and Salmeterol.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Advair HFA
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.